I begge undersøgelser var den tid det tog at forbedre patientens symptomer kortere hos de patienter, der tog Firazyr end hos dem, der tog tranexamsyre eller placebo.
In both studies, the time it took for the patient ’ s symptoms to improve was shorter for patients taking Firazyr than for those taking tranexamic acid or placebo.